Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy G Murray

Showing results (211-220 of 260) with videos related to

Pageof 26
Sort By:
Journal of Vitreoretinal Diseases|July 22, 2021
Sympathetic Ophthalmia in a 22-Month-Old Infant With Sturge-Weber Syndrome With Atypical Histopathological CorrelationLinda A Cernichiaro-Espinosa, Aaron S Gold, Audina M Berrocal, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|December 7, 2007
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomesDaniel M Miller, Anil S Vedula, Harry W Flynn, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 16, 2003
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapyDaniel A Sussman, Erika Escalona-Benz, Matthew S Benz, et al.
Investigative Ophthalmology & Visual Science|January 24, 2012
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumorsYolanda Piña, Christina Decatur, Timothy G Murray, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 16, 2012
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumorsYolanda Piña, Samuel K Houston, Timothy G Murray, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 12, 2004
Immediate postoperative use of a topical agent to prevent intraocular pressure elevation after pars plana vitrectomy with gas tamponadeMatthew S Benz, Erika M Escalona-Benz, Timothy G Murray, et al.
Investigative Ophthalmology & Visual Science|September 29, 2004
Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastomaBrandy C Hayden, Maria-Elena Jockovich, Timothy G Murray, et al.
Cancer Research|May 8, 2007
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cellsJacobus J Bosch, James A Thompson, Minu K Srivastava, et al.
Investigative Ophthalmology & Visual Science|June 6, 2015
Clinical and Echographic Features of Retinochoroidal and Optic Nerve ColobomasVincent D Venincasa, Yasha S Modi, Hassan A Aziz, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 9, 2011
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastomaLejla Mutapcic Vajzovic, Timothy G Murray, Mohammad A Aziz-Sultan, et al.
Pageof 26

Showing results (211-220 of 260) with videos related to

Sort By:
Pageof 26
Journal of Vitreoretinal Diseases|July 22, 2021
Sympathetic Ophthalmia in a 22-Month-Old Infant With Sturge-Weber Syndrome With Atypical Histopathological CorrelationLinda A Cernichiaro-Espinosa, Aaron S Gold, Audina M Berrocal, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|December 7, 2007
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomesDaniel M Miller, Anil S Vedula, Harry W Flynn, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 16, 2003
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapyDaniel A Sussman, Erika Escalona-Benz, Matthew S Benz, et al.
Investigative Ophthalmology & Visual Science|January 24, 2012
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumorsYolanda Piña, Christina Decatur, Timothy G Murray, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 16, 2012
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumorsYolanda Piña, Samuel K Houston, Timothy G Murray, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|May 12, 2004
Immediate postoperative use of a topical agent to prevent intraocular pressure elevation after pars plana vitrectomy with gas tamponadeMatthew S Benz, Erika M Escalona-Benz, Timothy G Murray, et al.
Investigative Ophthalmology & Visual Science|September 29, 2004
Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastomaBrandy C Hayden, Maria-Elena Jockovich, Timothy G Murray, et al.
Cancer Research|May 8, 2007
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cellsJacobus J Bosch, James A Thompson, Minu K Srivastava, et al.
Investigative Ophthalmology & Visual Science|June 6, 2015
Clinical and Echographic Features of Retinochoroidal and Optic Nerve ColobomasVincent D Venincasa, Yasha S Modi, Hassan A Aziz, et al.
Clinical Ophthalmology (Auckland, N.Z.)|March 9, 2011
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastomaLejla Mutapcic Vajzovic, Timothy G Murray, Mohammad A Aziz-Sultan, et al.
Pageof 26